ID17275A - N-[4-(heteroarilmetil)fenil]-heteroarilamina - Google Patents

N-[4-(heteroarilmetil)fenil]-heteroarilamina

Info

Publication number: ID17275A
Authority: ID; Indonesia
Prior art keywords: heteroarilmetil; heteroarilamina; fenil
Prior art date: 1996-06-27

Application number

IDP972217A

Other languages

English (en)

Indonesian (id)

Inventor

Marc Gaston Venet

Dominique Jean Pierre Mabire

Jean Fernand Armand Lacrampe

Gerard Charles Sanz

Original Assignee

Janssen Pharmaceutica Nv

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1996-06-27

Filing date

1997-06-26

Publication date

1997-12-18

1997-06-26 Application filed by Janssen Pharmaceutica Nv filed Critical Janssen Pharmaceutica Nv

1997-12-18 Publication of ID17275A publication Critical patent/ID17275A/id

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
- C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
- C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
- C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
- C07D513/04—Ortho-condensed systems

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Dermatology (AREA)
Epidemiology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Plural Heterocyclic Compounds (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)
Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

IDP972217A 1996-06-27 1997-06-26 N-[4-(heteroarilmetil)fenil]-heteroarilamina ID17275A (id)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
EP96201781		1996-06-27

Publications (1)

Publication Number	Publication Date
ID17275A true ID17275A (id)	1997-12-18

Family

ID=8224119

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
IDP972217A ID17275A (id)	1996-06-27	1997-06-26	N-[4-(heteroarilmetil)fenil]-heteroarilamina

Country Status (32)

Country	Link
US (5)	US6124330A (fr)
EP (1)	EP0907650B1 (fr)
JP (1)	JP3404749B2 (fr)
KR (1)	KR100365312B1 (fr)
CN (1)	CN1102593C (fr)
AR (1)	AR007626A1 (fr)
AT (1)	ATE229019T1 (fr)
AU (1)	AU711575B2 (fr)
BG (1)	BG63545B1 (fr)
BR (1)	BR9710002A (fr)
CA (1)	CA2258165C (fr)
CZ (1)	CZ297769B6 (fr)
DE (1)	DE69717627T2 (fr)
DK (1)	DK0907650T3 (fr)
EE (1)	EE03688B1 (fr)
ES (1)	ES2188957T3 (fr)
HU (1)	HU223093B1 (fr)
ID (1)	ID17275A (fr)
IL (1)	IL127740A (fr)
MY (1)	MY116917A (fr)
NO (1)	NO312102B1 (fr)
NZ (1)	NZ333382A (fr)
PL (1)	PL201704B1 (fr)
PT (1)	PT907650E (fr)
RU (1)	RU2190611C2 (fr)
SI (1)	SI0907650T1 (fr)
SK (1)	SK282769B6 (fr)
TR (1)	TR199802709T2 (fr)
TW (1)	TW490464B (fr)
UA (1)	UA53649C2 (fr)
WO (1)	WO1997049704A1 (fr)
ZA (1)	ZA975698B (fr)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE69717627T2 (de) *	1996-06-27	2003-09-18	Janssen Pharmaceutica N.V., Beerse	N-4-(heteroarylmethyl)phenyl-heteroarylaminderivate
EP1037880B1 (fr)	1997-12-11	2004-06-30	Janssen Pharmaceutica N.V.	Anilides mimetiques de l'acide retinoique
US6833373B1 (en)	1998-12-23	2004-12-21	G.D. Searle & Co.	Method of using an integrin antagonist and one or more antineoplastic agents as a combination therapy in the treatment of neoplasia
US6858598B1 (en)	1998-12-23	2005-02-22	G. D. Searle & Co.	Method of using a matrix metalloproteinase inhibitor and one or more antineoplastic agents as a combination therapy in the treatment of neoplasia
DE19951701A1 (de)	1999-10-27	2001-05-03	Aventis Pharma Gmbh	Verwendung von 2-Imidazolyl-substituierten Carbinolen zur Herstellung eines Medikaments zur Behandlung oder Prophylaxe von durch ischämischen Zuständen bewirkten Krankheiten
AU2003223672A1 (en) *	2002-04-17	2003-11-03	Tyco Healthcare Group Lp	Method and apparatus for anastomosis including an expandable anchor
AU2003284981B2 (en)	2002-10-30	2009-05-28	Merck Sharp & Dohme Corp.	Inhibitors of Akt activity
CN1809351A (zh)	2003-04-24	2006-07-26	麦克公司	Akt活性抑制剂
CN1984660B (zh)	2003-07-03	2010-12-15	美瑞德生物工程公司	作为天冬氨酸特异性半胱氨酸蛋白酶活化剂和细胞程序死亡诱导剂的4-芳基氨基-喹唑啉
US8309562B2 (en) *	2003-07-03	2012-11-13	Myrexis, Inc.	Compounds and therapeutical use thereof
WO2006074147A2 (fr)	2005-01-03	2006-07-13	Myriad Genetics, Inc.	Composes et utilisation therapeutique associee
DE10337942A1 (de) *	2003-08-18	2005-03-17	Merck Patent Gmbh	Aminobenzimidazolderivate
BRPI0516950A (pt) *	2004-09-24	2008-09-30	Allergan Inc	4-(metila cìclica condensada)-imidazol-2-tionas atuando como agonistas adrenérgicos alfa2
MX2007003068A (es)	2004-09-24	2007-05-21	Allergan Inc	4-(fenil-metil y fenil-metil substituido)-imidazol-2tionas como agonistas adrenergicos alfa2 especificos.
JP2008514603A (ja)	2004-09-24	2008-05-08	アラーガン、インコーポレイテッド	α２アドレナリン作動剤としての４−（ヘテロアリール−メチルおよび置換ヘテロアリール−メチル）−イミダゾール−２−チオン
NZ553566A (en) *	2004-09-28	2010-11-26	Allergan Inc	Unsubstituted and substituted 4-benzyl-1,3-dihydro-imidazole-2-thiones acting as specific or selective alpha2 adrenergic agonists and methods for using the same
US8258145B2 (en)	2005-01-03	2012-09-04	Myrexis, Inc.	Method of treating brain cancer
US7547782B2 (en) *	2005-09-30	2009-06-16	Bristol-Myers Squibb Company	Met kinase inhibitors
WO2007084542A2 (fr)	2006-01-17	2007-07-26	Barrier Therapeutics, Inc.	Traitement de troubles inflammatoires avec des composes de triazole
CA2667053C (fr)	2006-10-17	2015-04-28	Stiefel Laboratories, Inc.	Metabolites de talarazole
ES2361233T3 (es) *	2007-10-18	2011-06-15	Dompé S.p.A.	Derivados (r)-4-(heteroaril)feniletilo y composiciones farmacéuticas que los contienen.
GB0811091D0 (en) *	2008-06-17	2008-07-23	Cancer Rec Tech Ltd	CYP26 Inhibitors
US10414760B2 (en)	2016-11-29	2019-09-17	Angion Biomedica Corp.	Cytochrome P450 inhibitors and uses thereof
EP2576544A4 (fr)	2010-06-01	2013-09-11	Angion Biomedica Corp	Inhibiteurs des cytochromes p450 et leurs utilisations
KR101108577B1 (ko) *	2010-07-28	2012-01-30	국제엘렉트릭코리아 주식회사	테이프 히터
KR20180099933A (ko)	2010-11-19	2018-09-05	리간드 파마슈티칼스 인코포레이티드	복소환 아민 및 이의 용도
WO2013028771A1 (fr)	2011-08-23	2013-02-28	Leong Hwei Xian	Régression de l'inflammation intestinale sous l'effet de l'inhibition du métabolisme de l'acide rétinoïque
AU2015301891B2 (en)	2014-08-11	2019-12-05	Angion Biomedica Corporation	Cytochrome P450 inhibitors and uses thereof
EP3240778A4 (fr)	2014-12-31	2018-07-11	Angion Biomedica Corp.	Méthodes et agents pour traiter une maladie
US10807983B2 (en)	2015-03-16	2020-10-20	Ligand Pharmaceuticals, Inc.	Imidazo-fused heterocycles and uses thereof
CN106632051A (zh) *	2016-12-15	2017-05-10	青岛辰达生物科技有限公司	一种盐酸右美托咪定中间体的合成方法
CN106588779A (zh) *	2016-12-15	2017-04-26	青岛辰达生物科技有限公司	一种合成盐酸右美托咪定中间体的方法
CN106588780A (zh) *	2016-12-15	2017-04-26	青岛辰达生物科技有限公司	一种盐酸右美托咪定中间体的制备工艺
KR20210055340A (ko)	2019-11-07	2021-05-17	정화종	화물 커버
CN115462347B (zh) *	2021-08-13	2024-07-16	广州市妇女儿童医疗中心	视黄酸代谢通路在先天性巨结肠疾病中的应用

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO1986002073A1 (fr) *	1984-10-03	1986-04-10	Takeda Chemical Industries, Ltd.	Derives de thiazolidinedione, procede de preparation et composition pharmaceutique les contenant
NZ221729A (en) *	1986-09-15	1989-07-27	Janssen Pharmaceutica Nv	Imidazolyl methyl-substituted benzimidazole derivatives and pharmaceutical compositions
CA2002859C (fr) *	1988-11-29	1998-12-29	Jean P. F. Van Wauwe	Methode de traitement d'affections epitheliales
DK0482208T3 (da)	1990-04-25	2000-09-18	Nissan Chemical Ind Ltd	Pyridazinonderivat
ZW1992A1 (en) *	1991-02-25	1993-09-22	Janssen Pharmaceutica Nv	4-/(2-benzotiazolyl)methylamino/-b-/(3,4-difluorephenoxy)methyl/-1-piperidine ethanol
FR2677356B1 (fr) *	1991-06-05	1995-03-17	Sanofi Sa	Derives heterocycliques d'acylamino-2 thiazoles-5 substitues, leur preparation et compositions pharmaceutiques en contenant.
TW282469B (fr) *	1993-06-11	1996-08-01	Janssen Pharmaceutica Nv
TW321649B (fr)	1994-11-12	1997-12-01	Zeneca Ltd
US5582832A (en) *	1995-06-06	1996-12-10	Chesebrough-Pond's Usa Co., Division Of Conopco, Inc.	Compositions for topical application to skin
GB9624482D0 (en)	1995-12-18	1997-01-15	Zeneca Phaema S A	Chemical compounds
CA2242425C (fr)	1996-02-13	2006-07-18	Zeneca Limited	Derives de la quinazoline utilises comme inhibiteurs du vegf
US5731342A (en) *	1996-02-22	1998-03-24	Eli Lilly And Company	Benzothiophenes, formulations containing same, and methods
DE69717627T2 (de) *	1996-06-27	2003-09-18	Janssen Pharmaceutica N.V., Beerse	N-4-(heteroarylmethyl)phenyl-heteroarylaminderivate

1997
- 1997-06-19 DE DE69717627T patent/DE69717627T2/de not_active Expired - Lifetime
- 1997-06-19 CN CN97195865A patent/CN1102593C/zh not_active Expired - Lifetime
- 1997-06-19 CA CA002258165A patent/CA2258165C/fr not_active Expired - Lifetime
- 1997-06-19 NZ NZ333382A patent/NZ333382A/xx not_active IP Right Cessation
- 1997-06-19 CZ CZ0423198A patent/CZ297769B6/cs not_active IP Right Cessation
- 1997-06-19 WO PCT/EP1997/003248 patent/WO1997049704A1/fr not_active Ceased
- 1997-06-19 IL IL12774097A patent/IL127740A/en not_active IP Right Cessation
- 1997-06-19 EE EE9800437A patent/EE03688B1/xx unknown
- 1997-06-19 UA UA98116146A patent/UA53649C2/uk unknown
- 1997-06-19 AU AU34356/97A patent/AU711575B2/en not_active Expired
- 1997-06-19 EP EP97930378A patent/EP0907650B1/fr not_active Expired - Lifetime
- 1997-06-19 US US09/214,080 patent/US6124330A/en not_active Expired - Lifetime
- 1997-06-19 JP JP50232198A patent/JP3404749B2/ja not_active Expired - Lifetime
- 1997-06-19 PT PT97930378T patent/PT907650E/pt unknown
- 1997-06-19 SK SK1781-98A patent/SK282769B6/sk not_active IP Right Cessation
- 1997-06-19 SI SI9730478T patent/SI0907650T1/xx unknown
- 1997-06-19 DK DK97930378T patent/DK0907650T3/da active
- 1997-06-19 BR BR9710002A patent/BR9710002A/pt not_active IP Right Cessation
- 1997-06-19 ES ES97930378T patent/ES2188957T3/es not_active Expired - Lifetime
- 1997-06-19 HU HU9902138A patent/HU223093B1/hu active IP Right Grant
- 1997-06-19 KR KR10-1998-0709764A patent/KR100365312B1/ko not_active Expired - Lifetime
- 1997-06-19 PL PL330816A patent/PL201704B1/pl unknown
- 1997-06-19 RU RU99101902/04A patent/RU2190611C2/ru active
- 1997-06-19 TR TR1998/02709T patent/TR199802709T2/xx unknown
- 1997-06-19 AT AT97930378T patent/ATE229019T1/de active
- 1997-06-23 TW TW086108726A patent/TW490464B/zh not_active IP Right Cessation
- 1997-06-25 MY MYPI97002859A patent/MY116917A/en unknown
- 1997-06-26 ZA ZA975698A patent/ZA975698B/xx unknown
- 1997-06-26 AR ARP970102822A patent/AR007626A1/es active IP Right Grant
- 1997-06-26 ID IDP972217A patent/ID17275A/id unknown
1998
- 1998-12-14 BG BG103013A patent/BG63545B1/bg unknown
- 1998-12-21 NO NO19986017A patent/NO312102B1/no not_active IP Right Cessation
2000
- 2000-07-25 US US09/624,966 patent/US6486187B1/en not_active Expired - Lifetime
2002
- 2002-09-10 US US10/238,686 patent/US6833375B2/en not_active Expired - Lifetime
2004
- 2004-11-02 US US10/979,362 patent/US7205312B2/en not_active Expired - Fee Related
2006
- 2006-12-13 US US11/639,043 patent/US7378433B2/en not_active Expired - Fee Related

Also Published As

Publication number	Publication date
EP0907650A1 (fr)	1999-04-14
BG63545B1 (bg)	2002-04-30
UA53649C2 (uk)	2003-02-17
DE69717627T2 (de)	2003-09-18
EE9800437A (et)	1999-06-15
US6833375B2 (en)	2004-12-21
US7378433B2 (en)	2008-05-27
HUP9902138A3 (en)	2001-10-29
US7205312B2 (en)	2007-04-17
JP3404749B2 (ja)	2003-05-12
HUP9902138A2 (hu)	1999-10-28
SI0907650T1 (en)	2003-06-30
IL127740A0 (en)	1999-10-28
AR007626A1 (es)	1999-11-10
AU711575B2 (en)	1999-10-14
ES2188957T3 (es)	2003-07-01
US6486187B1 (en)	2002-11-26
CA2258165A1 (fr)	1997-12-31
MY116917A (en)	2004-04-30
SK282769B6 (sk)	2002-12-03
HU223093B1 (hu)	2004-03-29
KR100365312B1 (ko)	2003-03-06
DE69717627D1 (de)	2003-01-16
BR9710002A (pt)	1999-08-10
CA2258165C (fr)	2009-03-03
SK178198A3 (en)	2000-05-16
CN1102593C (zh)	2003-03-05
TR199802709T2 (xx)	1999-02-22
CZ423198A3 (cs)	1999-05-12
CN1223654A (zh)	1999-07-21
RU2190611C2 (ru)	2002-10-10
NZ333382A (en)	2000-05-26
PT907650E (pt)	2003-04-30
US20050113378A1 (en)	2005-05-26
PL201704B1 (pl)	2009-04-30
US20070088062A1 (en)	2007-04-19
TW490464B (en)	2002-06-11
ZA975698B (en)	1999-01-20
NO986017D0 (no)	1998-12-21
HK1018458A1 (en)	1999-12-24
IL127740A (en)	2001-09-13
DK0907650T3 (da)	2003-03-10
WO1997049704A1 (fr)	1997-12-31
PL330816A1 (en)	1999-06-07
US6124330A (en)	2000-09-26
KR20000016196A (ko)	2000-03-25
BG103013A (en)	1999-09-30
JP2000503670A (ja)	2000-03-28
EE03688B1 (et)	2002-04-15
NO312102B1 (no)	2002-03-18
AU3435697A (en)	1998-01-14
ATE229019T1 (de)	2002-12-15
EP0907650B1 (fr)	2002-12-04
NO986017L (no)	1999-02-19
US20030176419A1 (en)	2003-09-18
CZ297769B6 (cs)	2007-03-28

Publication	Publication Date	Title
ID17275A (id)	1997-12-18	N-[4-(heteroarilmetil)fenil]-heteroarilamina
MX209959B (es)	2002-08-26	4-(3-heterociclil-1-benzoil)pirazoles
DE69832185D1 (de)	2005-12-08	Dichroischer polarisator
ID17053A (id)	1997-12-04	Derivat-derivat 2-(2-okso-etiliden)-imidazolidin-4-on
FI953303A0 (fi)	1995-07-04	Uusi fytaasi
DE69721098D1 (de)	2003-05-28	Entwicklungsgerät
NO984316D0 (no)	1998-09-17	Skjµreverkt°y
DE69720097D1 (de)	2003-04-30	Entwicklungsgerät
NO983462D0 (no)	1998-07-28	Isoleringsverkt°y
NO982414D0 (no)	1998-05-27	Ny kombinasjon
DE69715313D1 (de)	2002-10-17	Entwicklungsgerät
ID18010A (id)	1998-02-19	Oligosakarida termodifikasi
NO20001494D0 (no)	2000-03-22	Overligger
NO990552D0 (no)	1999-02-05	Innrettingsverkt°y
PT1036083E (pt)	2004-10-29	Novos 9a-azalidos
NO993298L (no)	1999-07-02	Ny fremgangsmÕte
NO995796D0 (no)	1999-11-26	Ny fremgangsmåte
NO20002555D0 (no)	2000-05-18	Skjøt
DE69702724D1 (de)	2000-09-14	Vibrator
BR9710322A (pt)	1999-08-17	Tioamidas N-(5-isotiazolil) substituidas
DK0983266T3 (da)	2002-03-11	Hidtil ukendte tetrahydrosioquinolinthiophencarboximidamider
BR9507266A (pt)	1997-09-30	Refrigerador-frezzer independente portátil
DE69800370D1 (de)	2000-12-07	4-(Alkoxyhydroxy)styryl-triazin Photoinitiatoren
DE69824255D1 (de)	2004-07-08	Deformylase
BR9711681A (pt)	1999-08-24	Novos m-todos